Scott Kahn

Scott Kahn is a seasoned financial leader with over thirty five years of experience in diverse organizations from Fortune 500 companies to start-ups. Prior to joining StartonTherapeutics, Mr. Kahn served as CFO at Milestone Scientific, a publicly traded pharmaceutical manufacturer. Before Milestone Scientific, Mr. Kahn was CFO and Vice President of Diopsys for approximately fifteen years where he was responsible for all accounting, finance, human resources and investor relations. Prior to joining Diopsys, Mr. Kahn served as CFO at Diamond Chemical Co., Inc., a privately held chemical manufacturer. Prior to becoming CFO at Diamond Chemical Co. Inc., Mr. Kahn was a Corporate Controller of Pharmaceutical Formulations, Inc., a publicly traded pharmaceutical manufacturer. Previously, Mr. Kahn held various finance, strategy and operational leadership roles. Mr. Kahn received a B.A. in Accounting from Franklin and Marshall College and an M.B.A. in International Business from Rutgers University. He is a Certified Public Accountant licensed in the State of New York and a Chartered Global Management Accountant.